Questions and answers

Is breast cancer curable?

Yes, especially in the early stages; an evidence-based look at the chance of cure by stage and subtype

Updated: 28 October 20261 min read9 references
Short answer

Yes; most breast cancers that are found early are cured with standard treatment (surgery and, depending on the type of cancer, radiotherapy, hormone tablets, chemotherapy or targeted drugs) [1, 2]. In the United States, almost all women whose cancer was only in the breast, and more than 9 in 10 of all patients, are alive after 5 years [3]. Breast cancer that has spread to other parts of the body (stage 4) is usually treated with the aim of long-term control, and many patients live for years with controlled disease [4].

Key points

  • Deaths from breast cancer in the United States nearly halved from 1989 to 2022; that is more than half a million fewer deaths [5].
  • Finding it early matters: the US Preventive Services Task Force recommends mammography every 2 years for women aged 40 to 74 [6]. Have any new lump checked early (A breast lump: what should I do?).

What does "curable" mean in breast cancer?

When doctors talk about "curative treatment", they mean treatment that aims to remove the disease completely and stop it from coming back. This aim is achievable in breast cancer that has not spread (stages 1 to 3), and treatment is usually surgery with additional treatments [1, 2].

Statistics come from large numbers of patients and do not predict one person's future precisely. Each patient's outcome depends on how fast the tumour grows, how far it has spread, access to effective treatment and general health [8]. Completing treatment and taking tablets regularly makes a big difference (why?).

The chance of cure by stage

Out of every 10 women with breast cancer, how many are alive 5 years later? (United States) [3]
StageWhat it meansAbout 25 years agoToday
EarlyThe cancer is only in the breastAlmost allAlmost all
Spread nearbyHas reached the lymph nodes in the armpit or nearby tissue89
SpreadHas reached distant sites such as the bones, liver or lungs2 to 33

Compared with women of the same age without cancer. These numbers are averages of thousands of patients, and newer treatments are not yet fully reflected in them [3].

Breast cancer that has spread: treatable, though usually not completely

There is treatment for most cancers that have spread, and the aim is often to stop or slow the disease; some people live for years with controlled disease [4]. In breast cancer that has spread, medicines are chosen according to the type of tumour and its genetic tests, from targeted tablets to immunotherapy [1, 9].

What determines the chance of cure?

  • Tumour subtype: markers such as the oestrogen and progesterone receptors, HER2 and Ki-67, and genomic markers such as BRCA1 and BRCA2, set the course of treatment [1].
  • Treatment before surgery: in HER2-positive and triple-negative cancers, combined treatment before surgery (often with targeted drugs) is standard, and the response to it determines later treatment [1].
  • Hormone therapy: oestrogen receptor-positive tumours receive 5 to 10 years of hormone therapy, and the decision about chemotherapy is based on an individual risk assessment [1].
  • Stage at diagnosis: the earlier the disease is found, the greater the chance of cure [3].

Related questions

If 5 years have passed since my treatment, does that mean the cancer won't come back?

Not necessarily. In hormone-sensitive breast cancer, the disease can come back even 10 or 20 years later; the larger the tumour was or the more lymph nodes were involved, the higher this risk [7]. This is why long-term follow-up matters.

Does early detection really make a difference?

Yes, a very big one. Almost all women whose cancer was found early and only in the breast are alive 5 years later; when the cancer has spread, about 3 in 10 women are [3]. Regular mammograms help find the disease earlier [6].

Does every patient need chemotherapy?

No. In hormone-sensitive cancers, the decision about chemotherapy is based on each patient's risk [1]. The treatment team sets the exact plan based on the stage and type of cancer [2].

Related cancer types

References

9 references
Show all references, 6 with a study cardClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    Breast cancerLoibl S, Poortmans P, Morrow M, Denkert C, Curigliano G · The Lancet · 2021;397:1750-1769
    Study cardDOIPubMed Back to text: 1 2 3 4 5 6 7
  2. 2
    Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upLoibl S, André F, Bachelot T, Barrios C, Bergh J, Burstein H, et al · Annals of Oncology · 2024;35:159-182
    Study cardDOIPubMed Back to text: 1 2 3
  3. 3
    Cancer statistics, 2026Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A · CA A Cancer J Clinicians · 2026;76:e70043
    Study cardDOIPubMed Back to text: 1 2 3 4 5
  4. 4
    Metastatic Cancer: When Cancer SpreadsNational Cancer Institute · cancer.gov · 2026
    Source Back to text: 1 2
  5. 5
    Breast cancer statistics 2024Giaquinto AN, Sung H, Newman LA, Freedman RA, Smith RA, Star J, et al · CA A Cancer J Clinicians · 2024;74:477-495
  6. 6
    Screening for Breast CancerUS Preventive Services Task Force, Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, et al · JAMA · 2024;331:1918
    Study cardDOIPubMed Back to text: 1 2
  7. 7
    20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 YearsPan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, et al · N Engl J Med · 2017;377:1836-1846
  8. 8
    Common Cancer Myths and MisconceptionsNational Cancer Institute · cancer.gov · 2024
  9. 9
    ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancerGennari A, André F, Barrios C, Cortés J, de Azambuja E, DeMichele A, et al · Annals of Oncology · 2021;32:1475-1495

This page is based on reputable scientific sources and was last updated on 28 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.